A First of its Kind Approval Changes the Way We Think About Access

The Challenge

The Challenge

A clinical-stage pharmaceutical company faced a unique barrier in bringing its first product to market—seeking pan-tumor approval based on a genetic marker, rather than a traditional approval based on cancer type. They subsequently sought recognition for the product across relevant clinical compendia.

The IP Solution

The IP Solution

Our extensive experience shepherding dozens of products to market enabled us to develop a strategy unique to this product, opening access for patients to this practice-changing therapy. IP was critical in identifying how to make the best case for the product to the decision-makers at major guideline/compendia organizations.

Our well-established relationships with Key Opinion Leaders enabled us to gain insight through 1:1 engagement, as our meetings with leaders of compendia-developing organizations. IP’s talented team transformed this knowledge into action – providing medical writing assistance for compendia application submissions, planning and implementing an advisory board, and developing a publication strategy.

We engaged IP to help us identify KOLs in areas which our team didn’t have the level of comfort that we needed at the time, specifically Hematologists in Europe. Their execution was flawless.
Medical Director, Pharma/Biotech Company
The Result

The Results

Following FDA approval, the product was recognized across major clinical compendia for all approved indications, ensuring broad access for providers across the community and academic settings and ultimately for patients.

Related Case Studies

MSL Trainings

Medical Science Liaisons are key points of contact at point of care and with payers to communicate key scientific information.  To provide its client with a strong and informed MSL team, IP developed customized training solutions to ensure a cohesive approach to stakeholder engagement. 

Conference Engagement Strategy

Conferences provide an important opportunity to engage with multiple stakeholders as large groups or in smaller 1:1 settings.  IP leveraged its expertise to coordinate multiple types of engagements and gather key insights for its client.

KOL Development

In order to develop an engagement plan for a stakeholder community which was growing and complex, IP identified and engaged multiple tiers of opinion leaders ensuring the client was able to reach a broad customer audience.